“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Dividend stocks have historically outperformed non-dividend payers. Dividend stocks can make great long-term investments.

Which is the best dividend aristocrat to buy in 2020? A dividend stock battle of consumer goods and healthcare giants!

Learn about three different great dividend stock options. We cover why they are excellent choices and what strategy to use ...

The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these ...

I am a passive income investor. I make my money work for me and get more money to invest. This way, I can supplement my ...

Medtronic is approaching five decades of dividend growth. AbbVie rose to the challenge when its Humira patent expired, ...

Historically, Johnson & Johnson has been a fairly stable stock to own. Johnson & Johnson (NYSE: JNJ) has been a leading ...

According to a July 10, 2025 SEC filing, the firm exited its entire position in Johnson & Johnson during Q2 2025, selling all ...

Time is one of investors' greatest allies. With enough patience, even a relatively small sum of money invested in an ...

JNJ which has outperformed the S&P 500 and other large-cap healthcare peers in H1-2025, now faces a crucial test with Q2 ...

CIBC World Markets head of portfolio strategy Ian de Verteuil is confident that domestic dividend-paying sectors have ample ...